Needle-Free hope: new blood test may detect liver scarring without painful biopsy

NCT ID NCT06819917

Recruiting now Diagnosis Sponsor: Roche Diagnostics GmbH Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is collecting blood samples from 575 adults with fatty liver disease to find new, noninvasive tests that can detect liver scarring (fibrosis). Currently, doctors rely on a painful liver biopsy to check for scarring, but this research aims to replace that with a simple blood test. Participants will give blood and may also have a noninvasive ultrasound scan. The goal is to make diagnosis easier, safer, and more accessible for millions of people with fatty liver disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON ALCOHOLIC FATTY LIVER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON ALCOHOLIC FATTY LIVER NON-ALCOHOLIC FATTY LIVER DISEASE NON-ALCOHOLIC STEATOHEPATITIS

Contacts and locations

Locations

Hvidovre Hospital
RECRUITING

Copenhagen, Denmark
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
RECRUITING

Mainz, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.